Results 161 to 170 of about 10,260 (172)

Synthesis and biological activity of ester and ether analogues of α-galactosylceramide (KRN7000)

Carbohydrate Research, 2010
Masaru Taniguchi, Hiroyuki Koshino, Hiroshi Watarai   +2 more
exaly  

Treatment with Sulfatide or its Precursor, Galactosylceramide, Prevents Diabetes in NOD Mice

Autoimmunity, 2001
Karsten Buschard, Pam Fredman
exaly  

Facile synthesis of biotin-labelled α-galactosylceramide as antigen for invariant natural killer T cells

Tetrahedron, 2009
Yalong Zhang, Wenpeng Zhang
exaly  

Biochemistry and neuropathology of mice doubly deficient in synthesis and degradation of galactosylceramide†

Journal of Neuroscience Research, 2000
Brian Popko, Marie T Vanier, J Matsuda
exaly  

Drastically Abnormal Gluco- and Galactosylceramide Composition Does Not Affect Ganglioside Metabolism in the Brain of Mice Deficient in Galactosylceramide Synthase

Neurochemical Research, 1999
Brian Popko, Marie T Vanier, Timothy Coetzee   +2 more
exaly  

American Journal of Respiratory Cell and Molecular Biology

American Journal of Respiratory Cell and Molecular Biology, 2005
Takafumi Suda, Toshi Nagata, Yukio Koide
exaly  

A synthetic analog of α-galactosylceramide induces macrophage activation via the TLR4-signaling pathways

Biochemical Pharmacology, 2007
Chun-Cheng Lin, Shih-Kai Hung, Shu-Ling Fu   +2 more
exaly  

The nanoparticulation by octaarginine-modified liposome improves α-galactosylceramide-mediated antitumor therapy systemic administration

Journal of Controlled Release, 2013
Takashi Nakamura, Hideyoshi Harashima
exaly  

ACTIVATION OF NATURAL KILLER T CELLS BY α-GALACTOSYLCERAMIDE MEDIATES CLEARANCE OF BACTERIA IN MURINE URINARY TRACT INFECTION

Journal of Urology, 2005
Chikara Ohyama, Tetsurō Katō
exaly  

Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy

Vaccine, 2009
Chengfeng Xia, Cheng-Wen Liu, Jagannadha Sastry   +2 more
exaly